Intellia Therapeutics (NTLA) Stock Price
$8.96 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Intellia Therapeutics, AI stock picks, stock alerts and much more.
NTLA AI Stock Analysis
AI stock analysis for NTLA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Intellia Therapeutics (NTLA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Intellia Therapeutics (NTLA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Intellia Therapeutics (NTLA), currently trading at $8.96, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NTLA
-
Intellia Therapeutics, Inc.
-
Symbol
NTLA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
928.1M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.67 0.6% |
6 |
 |
Inovio Pharmaceuticals INO |
$2 0.00% |
3 |
 |
Moderna MRNA |
$26 2.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.61 7.2% |
7 |
 |
BridgeBio Pharma BBIO |
$41.14 3.4% |
7 |
News
NTLA Alternative Data
Web Traffic
Intellia Therapeutics receives an estimated 33429 monthly visitors to intelliatx.com.
-
Web Traffic
33429
-
Change from Previous Month
21.5%
-
3 Month Change
59.8%
-
YoY Change
59.8%
Twitter Followers
Intellia Therapeutics has 11,567 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.9% over the last month.
-
Twitter Followers
11567
-
Daily Change
0.1%
-
1 Month Change
0.9%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Instagram Followers
Intellia Therapeutics has 1,272 Instagram Followers on its main Instagram account, up by 1.2% over the last month.
-
Instagram Followers
1272
-
Daily Change
0.1%
-
1 Month Change
1.2%
-
3 Month Change
1.3%
-
YoY Change
1.3%
LinkedIn Followers
61,937 are following Intellia Therapeutics on LinkedIn, up by 0.8% over the last month.
-
LinkedIn Followers
61937
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
2.5%
Job Postings
Intellia Therapeutics currenly has an estimated 11 open job postings, up by 22.2% over the last month.
-
Job Postings
11
-
Daily Change
0%
-
1 Month Change
22.2%
-
3 Month Change
56%
-
YoY Change
56%
LinkedIn Employees
According to LinkedIn, Intellia Therapeutics has 458 employees, down by -1.7% over the last month.
-
LinkedIn Employees
458
-
Daily Change
0%
-
1 Month Change
1.7%
-
3 Month Change
10.4%
-
YoY Change
10.4%
Reddit Mentions
Intellia Therapeutics has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Intellia Therapeutics is 30 out of 100 (bearish).
-
Business Outlook
30
-
Change from Previous Month
0%
-
3 Month Change
3.4%
-
YoY Change
3.4%
News Mentions
Intellia Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
100%
NTLA Financials
NTLA Key Metrics
-
Total Revenue
$12.9M
-
Net Income
-$128.9M
-
Earnings per Share
-$1.3
-
Free cash flow
-$86.2M
-
EBITDA
-$133.9M
-
EBITDA Ratio
-10.3993
-
Total Assets
$1.2B
NTLA 2-year Revenue & Income
NTLA 2-year Free Cash Flow
NTLA Technicals
NTLA SMA
NTLA RSI
FAQ
What's the current price of Intellia Therapeutics (NTLA) Stock?
The price of an Intellia Therapeutics (NTLA) share is $8.96.
What's the market cap of Intellia Therapeutics?
The current market cap of Intellia Therapeutics is 928.1M.
Should I buy or sell NTLA?
Intellia Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Intellia Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Intellia Therapeutics a good investment?
The current analysis of Intellia Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Intellia Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Intellia Therapeutics (NTLA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Intellia Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Intellia Therapeutics (NTLA) that investors often compare it to?
Intellia Therapeutics (NTLA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Intellia Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Intellia Therapeutics' stock price to be around $8.69 in 2026. Starting from the current price of $8.96, this represents a 3% change in price, indicating a neutral outlook for the stock.
How to buy Intellia Therapeutics (NTLA) Stock?
Intellia Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Intellia Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.